Phosphonic Acid

Phosphonic Acid

SCHEMBL4427162

O=C1CC(c2ccccc2-c2ccccc2)N1.O=[PH](O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.42
CREBBP Q92793 2/20 0.41
F11 P03951 1/20 0.37
HDAC4 P56524 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
EDNRB P24530 2/20 0.36
EDNRA P25101 2/20 0.36
ALDH1A1 P00352 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
ADRA2A P08913 3/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 2/20 0.35
TSHR P16473 1/20 0.35
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL621942 0.92 BRD4 (0.47) BRD4CREBBPHDAC4HDAC2HDAC8
Phosphonic Acid SCHEMBL11578470 0.71 ALDH1A1 (0.52) HDAC4HDAC2HDAC8HDAC6ALDH1A1
SCHEMBL620338 0.71 AR (0.42) BRD4CREBBPALDH1A1KDM4EMAPT
SCHEMBL29144904 0.67 ADRA2A (0.41) BRD4CREBBPALDH1A1KDM4ECHRNB2
SCHEMBL6124228 0.66 TNKS2 (0.71) ALDH1A1KDM4EMAPTTSHR
SCHEMBL9295153 0.66 BRD4 (0.50) BRD4CREBBPALDH1A1KDM4EMAPT
SCHEMBL6247618 0.66 BRD4 (0.50) BRD4CREBBPALDH1A1KDM4EMAPT
SCHEMBL157619 0.66 BRD4 (0.50) BRD4CREBBPALDH1A1KDM4EMAPT
SCHEMBL25094661 0.65 CREBBP (0.33) BRD4CREBBPALDH1A1TSHR
SCHEMBL5083830 0.65 IDO1 (0.58) ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
CN-101222950-A Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids MICROBIA INC (US) 2008-07-16 CN disclosed
CN-101222950-A Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids MICROBIA INC (US) 2008-07-16 CN disclosed
EP-1896135-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS Microbia, Inc. (US) 2008-03-12 EP disclosed
EP-1896135-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS Microbia, Inc. (US) 2008-03-12 EP disclosed
WO-2006127893-A3 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA INC (US) 2007-03-08 WO disclosed
WO-2006127893-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA, INC. (US) 2006-11-30 WO disclosed
WO-2006127893-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA, INC. (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids PIK3CA, PPA1, PIK3CB BRD4 3758/4885CREBBP 2558/4885F11 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.